世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039063

遺伝子治療の世界市場(2024-2028)

TechNavio

Global gene therapy market 2024-2028

発刊日 2024/06/12

言語英語

体裁PDF/177ページ

ライセンス/価格177ページ

0000039063

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

遺伝子治療市場は2023年から2028年に67億3,800万米ドル、予測期間中のCAGRは23.31%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、特殊医薬品指定の増加、遺伝子治療に伴う利点、慢性疾患の罹患率の増加によって推進されています。

調査範囲

  • 市場セグメント
    ➣ 投与方法別
      ◇ 生体内
      ◇ 生体外
    ➣ 治療領域別
      ◇ 腫瘍学
      ◇ 中枢神経系
      ◇ 眼科
      ◇ 希少疾患
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

この調査では、今後数年間の遺伝子治療市場の成長を牽引する主な理由の1つとして、CVD および希少疾患に対する遺伝子治療の研究の増加が挙げられています。また、発展途上国における急速な成長の可能性と遺伝子治療の臨床パイプラインの増加により、市場で大きな需要が生まれるでしょう。

遺伝子治療市場に関するレポートは、次の分野をカバーしています。

  • 遺伝子治療市場の規模
  • 遺伝子治療市場の予測
  • 遺伝子治療市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Abeona Therapeutics Inc.
    ➣ Adaptimmune Therapeutics plc
    ➣ Adverum Biotechnologies Inc.
    ➣ Amgen Inc., Astellas Pharma Inc.
    ➣ Biogen Inc.
    ➣ bluebird bio Inc.
    ➣ Editas Medicine Inc.
    ➣ ElevateBio
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Generation Bio Co.
    ➣ Gilead Sciences Inc.
    ➣ Novartis AG
    ➣ Orchard Therapeutics Plc
    ➣ Poseida Therapeutics Inc.
    ➣ Sangamo Therapeutics Inc.
    ➣ Sibiono GeneTech Co. Ltd.
    ➣ Syncona Ltd.
    ➣ uniQure NV
    ➣ Voyager Therapeutics Inc.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Delivery Mode
Executive Summary - Chart on Market Segmentation by Therapy Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Gene Therapy Market 2018 - 2022
Historic Market Size - Data Table on Global Gene Therapy Market 2018 - 2022 ($ million)
4.2 Delivery Mode segment analysis 2018 - 2022
Historic Market Size - Delivery Mode Segment 2018 - 2022 ($ million)
4.3 Therapy Area segment analysis 2018 - 2022
Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Delivery Mode
6.1 Market segments
Chart on Delivery Mode - Market share 2023-2028 (%)
Data Table on Delivery Mode - Market share 2023-2028 (%)
6.2 Comparison by Delivery Mode
Chart on Comparison by Delivery Mode
Data Table on Comparison by Delivery Mode
6.3 In vivo - Market size and forecast 2023-2028
Chart on In vivo - Market size and forecast 2023-2028 ($ million)
Data Table on In vivo - Market size and forecast 2023-2028 ($ million)
Chart on In vivo - Year-over-year growth 2023-2028 (%)
Data Table on In vivo - Year-over-year growth 2023-2028 (%)
6.4 Ex vivo - Market size and forecast 2023-2028
Chart on Ex vivo - Market size and forecast 2023-2028 ($ million)
Data Table on Ex vivo - Market size and forecast 2023-2028 ($ million)
Chart on Ex vivo - Year-over-year growth 2023-2028 (%)
Data Table on Ex vivo - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Delivery Mode
Market opportunity by Delivery Mode ($ million)
Data Table on Market opportunity by Delivery Mode ($ million)

7 Market Segmentation by Therapy Area
7.1 Market segments
Chart on Therapy Area - Market share 2023-2028 (%)
Data Table on Therapy Area - Market share 2023-2028 (%)
7.2 Comparison by Therapy Area
Chart on Comparison by Therapy Area
Data Table on Comparison by Therapy Area
7.3 Oncology - Market size and forecast 2023-2028
Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Chart on Oncology - Year-over-year growth 2023-2028 (%)
Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.4 CNS - Market size and forecast 2023-2028
Chart on CNS - Market size and forecast 2023-2028 ($ million)
Data Table on CNS - Market size and forecast 2023-2028 ($ million)
Chart on CNS - Year-over-year growth 2023-2028 (%)
Data Table on CNS - Year-over-year growth 2023-2028 (%)
7.5 Ophthalmology - Market size and forecast 2023-2028
Chart on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Data Table on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Chart on Ophthalmology - Year-over-year growth 2023-2028 (%)
Data Table on Ophthalmology - Year-over-year growth 2023-2028 (%)
7.6 Rare diseases - Market size and forecast 2023-2028
Chart on Rare diseases - Market size and forecast 2023-2028 ($ million)
Data Table on Rare diseases - Market size and forecast 2023-2028 ($ million)
Chart on Rare diseases - Year-over-year growth 2023-2028 (%)
Data Table on Rare diseases - Year-over-year growth 2023-2028 (%)
7.7 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.8 Market opportunity by Therapy Area
Market opportunity by Therapy Area ($ million)
Data Table on Market opportunity by Therapy Area ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abeona Therapeutics Inc
Abeona Therapeutics Inc - Overview
Abeona Therapeutics Inc - Product / Service
Abeona Therapeutics Inc - Key offerings
12.4 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.5 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.6 Biogen Inc.
Biogen Inc. - Overview
Biogen Inc. - Product / Service
Biogen Inc. - Key news
Biogen Inc. - Key offerings
12.7 bluebird bio Inc.
bluebird bio Inc. - Overview
bluebird bio Inc. - Product / Service
bluebird bio Inc. - Key offerings
12.8 ElevateBio
ElevateBio - Overview
ElevateBio - Product / Service
ElevateBio - Key offerings
12.9 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.10 Generation Bio Co.
Generation Bio Co. - Overview
Generation Bio Co. - Product / Service
Generation Bio Co. - Key offerings
12.11 Gilead Sciences Inc.
Gilead Sciences Inc. - Overview
Gilead Sciences Inc. - Product / Service
Gilead Sciences Inc. - Key news
Gilead Sciences Inc. - Key offerings
12.12 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.13 Orchard Therapeutics Plc
Orchard Therapeutics Plc - Overview
Orchard Therapeutics Plc - Product / Service
Orchard Therapeutics Plc - Key offerings
12.14 Poseida Therapeutics Inc.
Poseida Therapeutics Inc. - Overview
Poseida Therapeutics Inc. - Product / Service
Poseida Therapeutics Inc. - Key news
Poseida Therapeutics Inc. - Key offerings
12.15 Sibiono GeneTech Co. Ltd.
Sibiono GeneTech Co. Ltd. - Overview
Sibiono GeneTech Co. Ltd. - Product / Service
Sibiono GeneTech Co. Ltd. - Key offerings
12.16 uniQure NV
uniQure NV - Overview
uniQure NV - Product / Service
uniQure NV - Key offerings
12.17 Voyager Therapeutics Inc
Voyager Therapeutics Inc - Overview
Voyager Therapeutics Inc - Product / Service
Voyager Therapeutics Inc - Key news
Voyager Therapeutics Inc - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy Area
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Gene Therapy Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Delivery Mode Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Delivery Mode - Market share 2023-2028 (%)
Exhibits33: Data Table on Delivery Mode - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Delivery Mode
Exhibits35: Data Table on Comparison by Delivery Mode
Exhibits36: Chart on In vivo - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on In vivo - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on In vivo - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on In vivo - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Ex vivo - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Ex vivo - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Ex vivo - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Ex vivo - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Delivery Mode ($ million)
Exhibits45: Data Table on Market opportunity by Delivery Mode ($ million)
Exhibits46: Chart on Therapy Area - Market share 2023-2028 (%)
Exhibits47: Data Table on Therapy Area - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Therapy Area
Exhibits49: Data Table on Comparison by Therapy Area
Exhibits50: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on CNS - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on CNS - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on CNS - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on CNS - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Ophthalmology - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Ophthalmology - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Ophthalmology - Year-over-year growth 2023-2028 (%)
Exhibits62: Chart on Rare diseases - Market size and forecast 2023-2028 ($ million)
Exhibits63: Data Table on Rare diseases - Market size and forecast 2023-2028 ($ million)
Exhibits64: Chart on Rare diseases - Year-over-year growth 2023-2028 (%)
Exhibits65: Data Table on Rare diseases - Year-over-year growth 2023-2028 (%)
Exhibits66: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits67: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits68: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits69: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits70: Market opportunity by Therapy Area ($ million)
Exhibits71: Data Table on Market opportunity by Therapy Area ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits105: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits106: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits107: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits108: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits109: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits110: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits111: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits112: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits115: Impact of drivers and challenges in 2023 and 2028
Exhibits116: Overview on criticality of inputs and factors of differentiation
Exhibits117: Overview on factors of disruption
Exhibits118: Impact of key risks on business
Exhibits119: Companies covered
Exhibits120: Matrix on companies position and classification
Exhibits121: Abeona Therapeutics Inc - Overview
Exhibits122: Abeona Therapeutics Inc - Product / Service
Exhibits123: Abeona Therapeutics Inc - Key offerings
Exhibits124: Amgen Inc. - Overview
Exhibits125: Amgen Inc. - Product / Service
Exhibits126: Amgen Inc. - Key news
Exhibits127: Amgen Inc. - Key offerings
Exhibits128: Astellas Pharma Inc. - Overview
Exhibits129: Astellas Pharma Inc. - Product / Service
Exhibits130: Astellas Pharma Inc. - Key news
Exhibits131: Astellas Pharma Inc. - Key offerings
Exhibits132: Biogen Inc. - Overview
Exhibits133: Biogen Inc. - Product / Service
Exhibits134: Biogen Inc. - Key news
Exhibits135: Biogen Inc. - Key offerings
Exhibits136: bluebird bio Inc. - Overview
Exhibits137: bluebird bio Inc. - Product / Service
Exhibits138: bluebird bio Inc. - Key offerings
Exhibits139: ElevateBio - Overview
Exhibits140: ElevateBio - Product / Service
Exhibits141: ElevateBio - Key offerings
Exhibits142: F. Hoffmann La Roche Ltd. - Overview
Exhibits143: F. Hoffmann La Roche Ltd. - Business segments
Exhibits144: F. Hoffmann La Roche Ltd. - Key news
Exhibits145: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits146: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits147: Generation Bio Co. - Overview
Exhibits148: Generation Bio Co. - Product / Service
Exhibits149: Generation Bio Co. - Key offerings
Exhibits150: Gilead Sciences Inc. - Overview
Exhibits151: Gilead Sciences Inc. - Product / Service
Exhibits152: Gilead Sciences Inc. - Key news
Exhibits153: Gilead Sciences Inc. - Key offerings
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key news
Exhibits157: Novartis AG - Key offerings
Exhibits158: Novartis AG - Segment focus
Exhibits159: Orchard Therapeutics Plc - Overview
Exhibits160: Orchard Therapeutics Plc - Product / Service
Exhibits161: Orchard Therapeutics Plc - Key offerings
Exhibits162: Poseida Therapeutics Inc. - Overview
Exhibits163: Poseida Therapeutics Inc. - Product / Service
Exhibits164: Poseida Therapeutics Inc. - Key news
Exhibits165: Poseida Therapeutics Inc. - Key offerings
Exhibits166: Sibiono GeneTech Co. Ltd. - Overview
Exhibits167: Sibiono GeneTech Co. Ltd. - Product / Service
Exhibits168: Sibiono GeneTech Co. Ltd. - Key offerings
Exhibits169: uniQure NV - Overview
Exhibits170: uniQure NV - Product / Service
Exhibits171: uniQure NV - Key offerings
Exhibits172: Voyager Therapeutics Inc - Overview
Exhibits173: Voyager Therapeutics Inc - Product / Service
Exhibits174: Voyager Therapeutics Inc - Key news
Exhibits175: Voyager Therapeutics Inc - Key offerings
Exhibits176: Inclusions checklist
Exhibits177: Exclusions checklist
Exhibits178: Currency conversion rates for US$
Exhibits179: Research methodology
Exhibits180: Information sources
Exhibits181: Data validation
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Data synthesis
Exhibits184: 360 degree market analysis
Exhibits185: List of abbreviations

この商品のレポートナンバー

0000039063

TOP